273 related articles for article (PubMed ID: 22172453)
1. Strategies for replacing myocytes with induced pluripotent stem in clinical protocols.
Hattori F; Fukuda K
Transplant Rev (Orlando); 2012 Jul; 26(3):223-32. PubMed ID: 22172453
[TBL] [Abstract][Full Text] [Related]
2. iPS cells: a source of cardiac regeneration.
Yoshida Y; Yamanaka S
J Mol Cell Cardiol; 2011 Feb; 50(2):327-32. PubMed ID: 21040726
[TBL] [Abstract][Full Text] [Related]
3. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
Iglesias-García O; Pelacho B; Prósper F
J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
[TBL] [Abstract][Full Text] [Related]
4. Another possible cell source for cardiac regenerative medicine: reprogramming adult fibroblasts to cardiomyocytes and endothelial progenitor cells.
Xie X; Sun A; Huang Z; Zhu W; Wang S; Zou Y; Ge J
Med Hypotheses; 2011 Mar; 76(3):365-7. PubMed ID: 21087827
[TBL] [Abstract][Full Text] [Related]
5. [Review of basic studies about the cardiac stem cell and regenerative medicine].
Tamura Y; Fukuda K
Nihon Rinsho; 2008 May; 66(5):908-14. PubMed ID: 18464509
[TBL] [Abstract][Full Text] [Related]
6. Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models.
Freund C; Mummery CL
J Cell Biochem; 2009 Jul; 107(4):592-9. PubMed ID: 19449339
[TBL] [Abstract][Full Text] [Related]
7. ES and iPS cell research for cardiovascular regeneration.
Yamashita JK
Exp Cell Res; 2010 Oct; 316(16):2555-9. PubMed ID: 20385126
[TBL] [Abstract][Full Text] [Related]
8. Pluripotent stem cell-based heart regeneration: from the developmental and immunological perspectives.
Lui KO; Bu L; Li RA; Chan CW
Birth Defects Res C Embryo Today; 2012 Mar; 96(1):98-108. PubMed ID: 22457181
[TBL] [Abstract][Full Text] [Related]
9. Stem cell sources for cardiac regeneration.
Roccio M; Goumans MJ; Sluijter JP; Doevendans PA
Panminerva Med; 2008 Mar; 50(1):19-30. PubMed ID: 18427385
[TBL] [Abstract][Full Text] [Related]
10. Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells.
Xi J; Khalil M; Shishechian N; Hannes T; Pfannkuche K; Liang H; Fatima A; Haustein M; Suhr F; Bloch W; Reppel M; Sarić T; Wernig M; Jänisch R; Brockmeier K; Hescheler J; Pillekamp F
FASEB J; 2010 Aug; 24(8):2739-51. PubMed ID: 20371616
[TBL] [Abstract][Full Text] [Related]
11. A novel method to inhibit apoptosis and promote differentiation of induced pluripotent stem cells in transplantation therapy for myocardial infarction.
Li J; Han Y; Yan C; Kang J; Peng C; Zhang N; Zhang H
Med Hypotheses; 2011 Feb; 76(2):264-5. PubMed ID: 21041038
[TBL] [Abstract][Full Text] [Related]
12. Strategies for heart regeneration: approaches ranging from induced pluripotent stem cells to direct cardiac reprogramming.
Yamakawa H; Ieda M
Int Heart J; 2015; 56(1):1-5. PubMed ID: 25742939
[TBL] [Abstract][Full Text] [Related]
13. [Beating heart cells--targeted diagnostics, individual optimization of therapy and tailored cell therapies].
Kankuri E; Harjula A; Pätilä T; Penttinen K; Aalto-Setälä K
Duodecim; 2014; 130(19):2001-8. PubMed ID: 25558621
[TBL] [Abstract][Full Text] [Related]
14. Progenitor cell therapy for heart disease.
Gonzales C; Pedrazzini T
Exp Cell Res; 2009 Nov; 315(18):3077-85. PubMed ID: 19747911
[TBL] [Abstract][Full Text] [Related]
15. Prospects of induced pluripotent stem cell technology in regenerative medicine.
Zhang F; Citra F; Wang DA
Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts.
Shiba Y; Gomibuchi T; Seto T; Wada Y; Ichimura H; Tanaka Y; Ogasawara T; Okada K; Shiba N; Sakamoto K; Ido D; Shiina T; Ohkura M; Nakai J; Uno N; Kazuki Y; Oshimura M; Minami I; Ikeda U
Nature; 2016 Oct; 538(7625):388-391. PubMed ID: 27723741
[TBL] [Abstract][Full Text] [Related]
17. Myocardial regeneration by embryonic stem cell transplantation: present and future trends.
Dai W; Kloner RA
Expert Rev Cardiovasc Ther; 2006 May; 4(3):375-83. PubMed ID: 16716098
[TBL] [Abstract][Full Text] [Related]
18. Transplantation of embryonic stem cell-derived cardiomyocytes improves cardiac function in infarcted rat hearts.
Cai J; Yi FF; Yang XC; Lin GS; Jiang H; Wang T; Xia Z
Cytotherapy; 2007; 9(3):283-91. PubMed ID: 17464760
[TBL] [Abstract][Full Text] [Related]
19. Pluripotent reprogramming and lineage reprogramming: promises and challenges in cardiovascular regeneration.
He WJ; Hou Q; Han QW; Han WD; Fu XB
Tissue Eng Part B Rev; 2014 Aug; 20(4):304-13. PubMed ID: 24063625
[TBL] [Abstract][Full Text] [Related]
20. Scalable production of cardiomyocytes derived from c-Myc free induced pluripotent stem cells.
Zwi-Dantsis L; Mizrahi I; Arbel G; Gepstein A; Gepstein L
Tissue Eng Part A; 2011 Apr; 17(7-8):1027-37. PubMed ID: 21087204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
